Patent · US Active

Formulations for treating pain

US10052296B2 · kind B2 · utility

1Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2017
Grant dateAug 21, 2018
Priority date
Expiry dateApr 7, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Formulations, methods of manufacturing, methods of stabilizing, kits, and uses as medicament are provided, for example for the treatment of pain. The formulations can comprise gabapentin optionally combined with at least one non-opioid pain drug in an aqueous carrier. The pharmaceutical formulation can have a pH of about 2.0 to about 10.0. The at least one non-opioid pain drug can be acetaminophen. The components can be included in any amount suitable for purposes of obtaining properties desirable for an injectable infusion, for example an intravenous infusion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.